Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Epizyme, Inc. | 8,994 | reported | 12 Aug 2022 | tx 9+155,265−17,054 |
| RAPT Therapeutics, Inc. | 0 | reported | 03 Mar 2026 | tx 24+373,278−86,354 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | TENDER | RAPT Therapeutics, Inc. | 4,956 | — | |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 824 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 402 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 799 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 938 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 1,063 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 938 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 32,229 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 4,561 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 1,618 | — | deriv |
| 30 Jan 2026 | GRANT_AWARD | RAPT Therapeutics, Inc. | 4,956 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | RAPT Therapeutics, Inc. | 257,832 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | RAPT Therapeutics, Inc. | 36,490 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | RAPT Therapeutics, Inc. | 12,940 | 0.00 USD | deriv |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 8,060 | — | |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 8,994 | — | |
| 25 May 2022 | GRANT_AWARD | RAPT Therapeutics, Inc. | 8,500 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 8,994 | 0.00 USD | |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 41,006 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | RAPT Therapeutics, Inc. | 3,213 | 16.80 USD | deriv |
| 28 May 2021 | GRANT_AWARD | RAPT Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | Epizyme, Inc. | 8,060 | 0.00 USD | |
| 11 Jun 2021 | GRANT_AWARD | Epizyme, Inc. | 40,559 | 0.00 USD | deriv |
| 25 Jun 2020 | SALE | RAPT Therapeutics, Inc. | 19,013 | 33.37 USD | |
| 25 Jun 2020 | EXERCISE | RAPT Therapeutics, Inc. | 10,069 | 6.18 USD |